Feed & Nutrition
PhageTe™ Type II (百噬特Ⅱ型)
Primary Indications: PhageTe™ Type II is engineered with synergistic multivalent phages to eliminate complex, multidrug-resistant (MDR) Salmonella strains across poultry and livestock herds.
Target Pathogens: PhageTe Type II, Multidrug-Resistant Salmonella, Phage Cocktail, Cross-Serotype Lysis
📋 Technical Specifications & Usage Guidelines
Scientific Overview & Mode of Action
PhageTe™ Type II is engineered with synergistic multivalent phages to eliminate complex, multidrug-resistant (MDR) Salmonella strains across poultry and livestock herds.
Guaranteed Specifications & Composition
- Active: Synergistic Multivalent Lytic Salmonella Phage Cocktail
- Titer: ≥ 2.0 × 10⁹ PFU/g
- Carrier Viable: Probiotic carrier ≥ 5.0 × 10⁸ CFU/g
- Moisture: ≤ 12.0%
- Metals: Pb ≤ 40 mg/kg, As ≤ 10 mg/kg
Indications & Clinical Efficacy
Broad-spectrum cross-serovar lysis covering clinical MDR and ESBL-producing Salmonella isolates (S. enteritidis, S. typhimurium, S. infantis, S. derby).
📋 Recommended Dosage & Administration
Feed mix: 300–500 g per metric ton feed continuously.